Liensinine alleviates high fat diet (HFD)-induced non-alcoholic fatty liver disease (NAFLD) through suppressing oxidative stress and inflammation via regulating TAK1/AMPK signaling - Liang, L; Ye, S; Jiang, R; Zhou, X; Zhou, J; Meng, S (Int Immunopharmacol, 2022)